Search
Search Results
-
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
1825PDF: 483SUPPLEMENTARY MATERIAL: 291GRAPHICAL ABSTRACT: 258HTML: 4 -
The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis
2251PDF: 612Conflict of interest: 309SUPPLEMENTARY MATERIAL: 248HTML: 25 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
694PDF: 153Supplementary: 140Appendix: 103HTML: 3 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
689PDF: 160Supplementary: 133Appendix: 104HTML: 0 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1012pdf: 204Supplementary Material: 35HTML: 76 -
Pulmonary artery pressure sensor device performance in patients with atrial fibrillation/flutter
2299PDF: 423APPENDIX: 367HTML: 13 -
The association of iron deficiency with right ventricular dysfunction in Africans with heart failure
2158PDF: 365Appendix B: 423Appendix A: 312HTML: 1 -
Modulation of cardiac metabolism in heart failure
2273PDF: 956HTML: 4 -
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
498PDF: 1551Supplementary: 192Appendix: 137HTML: 11 -
-
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
3224PDF: 445Appendix: 360HTML: 20 -
iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025
9913PDF: 6232Appendix: 1001 -
Epidemiology of peripartum cardiomyopathy in Africa
2119PDF: 467HTML: 30 -
Evolving targets for heart failure: the journey so far
1916pdf: 267HTML: 4